UB17:LSE:LSE-UBS MSCI EMU Value UCITS EUR Adis (GBX)

ETF | Others |

Last Closing

USD 3901

Change

-5.75 (-0.15)%

Market Cap

N/A

Volume

77.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-21 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

-28.00 (-12.84%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+1.10 (+0.80%)

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.08 (+0.46%)

USD 581.04B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.05 (+0.32%)

USD 581.04B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-0.25 (-0.39%)

USD 266.08B
0QZO:LSE 0QZO

+1.20 (+1.12%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

+0.16 (+0.56%)

USD 239.13B
0QZ3:LSE Qualcomm Inc.

+1.52 (+0.92%)

USD 202.26B
0R24:LSE Intel Corp.

-0.28 (-1.26%)

USD 196.14B

ETFs Containing UB17:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.16% 86% B+ 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.16% 86% B+ 80% B-
Trailing 12 Months  
Capital Gain 10.73% 48% F 55% F
Dividend Return 0.04% 26% F 23% F
Total Return 10.77% 46% F 54% F
Trailing 5 Years  
Capital Gain 19.42% 46% F 59% D-
Dividend Return 0.17% 31% F 43% F
Total Return 19.60% 44% F 57% F
Average Annual (5 Year Horizon)  
Capital Gain 8.15% 56% F 61% D-
Dividend Return 8.15% 56% F 61% D-
Total Return 0.00% 18% F 11% F
Risk Return Profile  
Volatility (Standard Deviation) 12.31% 57% F 74% C
Risk Adjusted Return 66.22% 67% D+ 79% B-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.